B Cells Contribute to the Antitumor Activity of CpG-Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

(2010) David J. DiLillo et al.   Annals of the New York Academy of Sciences

Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma

(2010) A. Anichini et al.   CANCER RESEARCH

DC subsets in positive and negative regulation of immunity

(2010) Caroline Coquerelle et al.   IMMUNOLOGICAL REVIEWS

Regulatory B cells that produce IL-10: A breath of fresh air in allergic airway disease

(2010) Thomas F. Tedder et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

(2010) Cesar A. Corzo et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Plasmacytoid Dendritic Cells Alter the Antitumor Activity of CpG-Oligodeoxynucleotides in a Mouse Model of Lung Carcinoma

(2010) R. Sorrentino et al.   JOURNAL OF IMMUNOLOGY

Differential Suppression of Tumor-Specific CD8+ T Cells by Regulatory T Cells

(2010) E. James et al.   JOURNAL OF IMMUNOLOGY

B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

(2010) D. J. DiLillo et al.   JOURNAL OF IMMUNOLOGY

Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer

(2009) Gina Lee et al.   CURRENT OPINION IN PULMONARY MEDICINE

Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases

(2009) Xiaoyu Hu et al.   IMMUNITY

Mechanism and Regulatory Function of CpG Signaling via Scavenger Receptor B1 in Primary B Cells

(2009) Peimin Zhu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy

(2009) Q. Li et al.   JOURNAL OF IMMUNOLOGY

Toll-like receptors expressed in tumor cells: targets for therapy

(2008) Li Yu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clinical investigations of Toll-like receptor agonists

(2008) Thomas Meyer et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Toll-like receptors, wound healing, and carcinogenesis

(2008) Johannes Kluwe et al.   JOURNAL OF MOLECULAR MEDICINE-JMM